ADALIMUMAB AND INFLIXIMAB
NICE Appraisal
DSU Reports
DSU response to comments on DSU Crohn’s Report 2 (August 2009)
Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn’s Disease (January 2009)
ADALIMUMAB AND INFLIXIMAB
DSU response to comments on DSU Crohn’s Report 2 (August 2009)
Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab and infliximab) for Crohn’s Disease (January 2009)